Regeneron Pharmaceuticals Inc (REGN)
843.60
+5.40
(+0.64%)
USD |
NASDAQ |
Nov 01, 16:00
843.60
0.00 (0.00%)
After-Hours: 20:00
Regeneron Pharmaceuticals Shareholders Equity (Quarterly): 29.33B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 29.33B |
June 30, 2024 | 28.21B |
March 31, 2024 | 26.99B |
December 31, 2023 | 25.97B |
September 30, 2023 | 24.90B |
June 30, 2023 | 24.02B |
March 31, 2023 | 23.50B |
December 31, 2022 | 22.66B |
September 30, 2022 | 21.44B |
June 30, 2022 | 20.69B |
March 31, 2022 | 19.91B |
December 31, 2021 | 18.77B |
September 30, 2021 | 17.26B |
June 30, 2021 | 15.13B |
March 31, 2021 | 11.98B |
December 31, 2020 | 11.03B |
September 30, 2020 | 10.13B |
June 30, 2020 | 9.057B |
March 31, 2020 | 12.13B |
December 31, 2019 | 11.09B |
September 30, 2019 | 10.50B |
June 30, 2019 | 9.756B |
March 31, 2019 | 9.445B |
December 31, 2018 | 8.757B |
September 30, 2018 | 7.868B |
Date | Value |
---|---|
June 30, 2018 | 7.186B |
March 31, 2018 | 6.568B |
December 31, 2017 | 6.144B |
September 30, 2017 | 6.052B |
June 30, 2017 | 5.521B |
March 31, 2017 | 4.866B |
December 31, 2016 | 4.449B |
September 30, 2016 | 4.491B |
June 30, 2016 | 4.077B |
March 31, 2016 | 3.765B |
December 31, 2015 | 3.655B |
September 30, 2015 | 3.297B |
June 30, 2015 | 3.338B |
March 31, 2015 | 2.971B |
December 31, 2014 | 2.550B |
September 30, 2014 | 2.552B |
June 30, 2014 | 2.369B |
March 31, 2014 | 2.211B |
December 31, 2013 | 1.952B |
September 30, 2013 | 1.690B |
June 30, 2013 | 1.493B |
March 31, 2013 | 1.406B |
December 31, 2012 | 1.245B |
September 30, 2012 | 806.02M |
June 30, 2012 | 594.66M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
9.057B
Minimum
Jun 2020
29.33B
Maximum
Sep 2024
19.21B
Average
20.30B
Median
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 7.527B |
Eli Lilly and Co | 14.24B |
Pfizer Inc | 87.70B |
Biogen Inc | 16.36B |
Vertex Pharmaceuticals Inc | 14.77B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 37.44B |
Total Liabilities (Quarterly) | 8.116B |
Debt to Equity Ratio | 0.0677 |
Current Ratio | 5.281 |
Net Debt Paydown Yield | -0.00% |